As May is widely recognized as Skin Cancer Awareness Month, the team here at ImPACT would like to take this time to remind our readers about the very important intersection between military service and melanoma. Read More ›
The FDA has approved ustekinumab-stba (Steqeyma; Celltrion) for subcutaneous injection or intravenous infusion in adult and pediatric patients with plaque psoriasis and psoriatic arthritis, as well as adult patients with Crohn’s disease and ulcerative colitis. Read More ›
